Caffeine attenuates lipid accumulation via activation of AMP-activated protein kinase signaling pathway in HepG2 cells
2
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
The main purpose of this study is to examine the effect of caffeine on lipid accumulation in human hepatoma HepG2cells. Significant decreases in the accumulation of hepatic lipids, such as triglyceride (TG), and cholesterol were observed when HepG2 cells were treated with caffeine as indicated. Caffeine decreased the mRNA level of lipogenesis-associated genes (SREBP1c, SREBP2, FAS, SCD1, HMGR and LDLR). In contrast, mRNA level of CD36, which is responsible for lipid uptake and catabolism, was increased. Next, the effect of caffeine on AMP-activated protein kinase (AMPK) signaling pathway was examined. Phosphorylation of AMPK and acetyl-CoA carboxylase were evidently increased when the cells were treated with caffeine as indicated for 24 h. These effects were all reversed in the presence of compound C, an AMPK inhibitor. In summary, these data indicate that caffeine effectively depleted TG and cholesterol levels by inhibition of lipogenesis and stimulation of lipolysis through modulating AMPK-SREBP signaling pathways.
Abstract
The main purpose of this study is to examine the effect of caffeine on lipid accumulation in human hepatoma HepG2cells. Significant decreases in the accumulation of hepatic lipids, such as triglyceride (TG), and cholesterol were observed when HepG2 cells were treated with caffeine as indicated. Caffeine decreased the mRNA level of lipogenesis-associated genes (SREBP1c, SREBP2, FAS, SCD1, HMGR and LDLR). In contrast, mRNA level of CD36, which is responsible for lipid uptake and catabolism, was increased. Next, the effect of caffeine on AMP-activated protein kinase (AMPK) signaling pathway was examined. Phosphorylation of AMPK and acetyl-CoA carboxylase were evidently increased when the cells were treated with caffeine as indicated for 24 h. These effects were all reversed in the presence of compound C, an AMPK inhibitor. In summary, these data indicate that caffeine effectively depleted TG and cholesterol levels by inhibition of lipogenesis and stimulation of lipolysis through modulating AMPK-SREBP signaling pathways.
참고문헌 (23)
- Marchesini, G., "Nonalcoholic fatty liver disease: a feature of the metabolic syndrome", Diabetes, 50, pp.1884~1850 (2001)
- Hardie, D. G., "AMPK: a key regulator of energy balance in the single cell and the whole organism", Int. J. Obes, 32, pp.S7~S12 (2008)
- Hardie, D. G., "Regulation of lipid metabolism by the AMP-activated protein kinase", Biochem. Soc. Trans, 25, pp.1229~1231 (1997)
- Porstmann, T., "SREBP activity is regulated by mTORC1 and contributes to Akt-dependent cell growth", Cell Metab, 8, pp.224~236 (2008)
- You, M., "The role of AMP-activated protein kinase in the action of ethanol in the liver", Gastroenterology, 127, pp.1798~1808 (2004)
- Lee, W. J., "AMPK activation increases fatty acid oxidation in skeletal muscle by activating PPARa and PGC-1", Biochem. Biophys. Res. Commun, 340, pp.281~295 (2006)
- Keijzers, G. B., "Caffeine can decrease insulin sensitivity in humans", Diabetes Care, 25, pp.364~369 (2002)
- Duffey, K. J., "Shifts in patterns and consumption of beverages between 1965 and 2002", Obesity, 15, pp.2739~2747 (2002)
- Paynter, N. P., "Coffee and sweetened beverage consumption and the risk of type 2 diabetes mellitus: the atherosclerosis risk in communities study", Am. J. Epidemiol, 164, pp.1075~1084 (2006)
- Tuomilehto, J., "Coffee consumption and risk of type 2 diabetes mellitus among middle-aged Finnish men and women", JAMA, 291, pp.1213~1219 (2004)
- McCarty, M. F., "A chlorogenic acid-induced increase in GLP-1 production may mediate the impact of heavy coffee consumption on diabetes risk", Med. Hypotheses, 64, pp.848~853 (2005)
- Nakabayashi, H., "Inhibitory effects of caffeine and its metabolites on intracellular lipid accumulation in murine 3T3-L1 adipocytes", Biofactors, 34, pp.293~302 (2008)
- Murosaki, S., "A combination of caffeine, arginine, soy isoflavones, and L-carnitine enhances both lipolysis and fatty acid oxidation in 3T3-L1 and HepG2 cells in vitro and in KK mice in vivo", J. Nutr, 137, pp.2252~2257 (2007)
- Eberle, D., "SREBP transcription factors: master regulators of lipid homeostasis", Biochimi, 86, pp.839~848 (2004)
- Kim, S. J., "Anti-obesity effects of Juniperus chinensis extract are associated with increased AMP-activated protein kinase expression and phosphorylation in the visceral adipose tissue of rats.", Biol. Pharm. Bull, 31, pp.415~421 (2008)
- Ching, Y. P., "Analysis of the specificity of the AMP-activated protein kinase by site-directed mutagenesis of bacterially expressed 3-hydroxy 3-methylglutaryl-CoA reductase, using a single primer variant of the unique-site-elimination method", Eur. J. Biochem, 237, pp.800~808 (1996)
- Pallottini, V., "Mechanisms underlying the impaired regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase in aged rat liver", Mech. Ageing Dev, 125, pp.633~639 (2004)
- "Department of Agriculture Agricultural Research Service: USDA. National Nutrient Database for Standard Reference", ~ (2007)
- Nagle, C. A., "Hepatic triacylglycerol accumulation and insulin resistance", J. Lipid Res, 50, pp.S74~S79 (2009)
- Summers, S. A., "Ceramide in insulin resistance and lipotoxicity", Prog. Lipid Res, 45, pp.42~72 (2006)
- Horton, J. D., "SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver", J. Clin. Invest, 109, pp.1125~1131 (2002)
- Saha, A. K., "Malonyl-CoA and AMP-activated protein kinase: an expanding partnership", Mol. Cell Biochem, 253, pp.65~70 (2003)
- Hardie, D. G., "Regulation of fatty acid synthesis and oxidation by the AMP-activated protein kinase", Biochem. Soc. Trans, 30, pp.1064~1070 (2002)